Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595543 · ClinicalTrials.gov registry record · Phase 4
Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%
A Phase 4 study of Acute Pseudophakic Cystoid Macular Edema, sponsored by Bp Consulting.
- Completed
- Registry status
- Phase 4
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT00595543: Completed Phase 4 study of Acute Pseudophakic Cystoid Macular Edema, sponsored by Bp Consulting.
NCT00595543 is a Phase 4 study of Acute Pseudophakic Cystoid Macular Edema that has completed, run by Bp Consulting. The registered enrollment target is 166 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00595543, a Phase 4 study of Acute Pseudophakic Cystoid Macular Edema, has completed, sponsored by Bp Consulting.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
Conditions Studied
Interventions
- DRUG Ketorolac
- DRUG Diclofenac
- DRUG Bromfenac
Study Locations (1)
Pennsylvania
- Soll Eye Associates - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-03 |
| Phase | Phase 4 |
What the finished NCT00595543 record still lists
NCT00595543 is an interventional study that assigns participants to a tested intervention. The registered 166 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Acute Pseudophakic Cystoid Macular Edema appearing as the primary indexed condition, and to 3 interventions - of which Ketorolac is the first listed.
NCT00595543 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00595543 about?
NCT00595543 is a clinical study titled "Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%". To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.
What is the current status of trial NCT00595543?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 166 participants. The study started on 2008-01. Estimated completion is 2009-03.
What conditions does trial NCT00595543 study?
This clinical trial studies the following conditions: Acute Pseudophakic Cystoid Macular Edema.
What interventions are being tested in trial NCT00595543?
The interventions under investigation include: Ketorolac (DRUG), Diclofenac (DRUG), Bromfenac (DRUG).
Who is sponsoring clinical trial NCT00595543?
This trial is sponsored by Bp Consulting, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00595543 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00595543's enrollment target sits among peer trials
166 489th of 2000 higher than 1,510 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747303 · 166 participants · Phase 2
Frameless Stereotactic Radiosurgery for Intact Brain Metastases
- NCT03806283 · 166 participants
Mechanisms of Pregnancy Vascular Adaptations
- NCT04040452 · 166 participants · Phase 4
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- NCT04375813 · 166 participants · Phase 2
Trial of Encapsulated Rapamycin (eRapa) for Bladder Cancer Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia